Apotheek Devos

The annual accounts of Apotheek Devos for financial year 2025 show a net loss of 64% of the equity at the start of that year. The 2025 annual accounts show equity of €13,338 and a net result of -€24,132. Equity is shrinking by about 12% per year across the filed financial years. Its solvency ranks better than 13% of 4,937 sector peers (NACE 47, financial year 2025). The company has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.8% (low).